TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

Benzinga Logo Benzinga By Vandana Singh
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

Pfizer filed a lawsuit against Metsera and Novo Nordisk in Delaware Court, alleging antitrust violations and breach of contract after Novo Nordisk made an unsolicited $9 billion acquisition proposal that could disrupt Pfizer's planned $4.9 billion acquisition of Metsera.

Insights
PFE   negative

Actively pursuing legal action to block a competing acquisition proposal, indicating defensive strategic positioning